VARS2 V552V variant as prognostic marker in patients with early breast cancer. - sprookjes - yvandenbroek - TriplyDB

VARS2 V552V variant as prognostic marker in patients with early breast cancer.

VARS2 V552V variant as prognostic marker in patients with early breast cancer.

http://www.wikidata.org/entity/Q33587746

about

Accurate computation of survival statistics in genome-wide studies Association of VARS2-SFTA2 polymorphisms with the risk of chronic hepatitis B in a Korean population.

P2860

Q35581820-710DD553-983D-40F9-82C4-6EC4514E553E Q41657906-1E4EB938-8FDF-4081-9C45-E1BC30CEA23E

P2860

VARS2 V552V variant as prognostic marker in patients with early breast cancer.

http://www.wikidata.org/entity/Q33587746

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

VARS2 V552V variant as prognostic marker in patients with early breast cancer.

@ast

VARS2 V552V variant as prognostic marker in patients with early breast cancer.

@en

VARS2 V552V variant as prognostic marker in patients with early breast cancer.

@nl

type

label

VARS2 V552V variant as prognostic marker in patients with early breast cancer.

@ast

VARS2 V552V variant as prognostic marker in patients with early breast cancer.

@en

VARS2 V552V variant as prognostic marker in patients with early breast cancer.

@nl

prefLabel

VARS2 V552V variant as prognostic marker in patients with early breast cancer.

@ast

VARS2 V552V variant as prognostic marker in patients with early breast cancer.

@en

VARS2 V552V variant as prognostic marker in patients with early breast cancer.

@nl

P1433

Q33587746-E95C75AB-61BF-4929-A10D-AABC311ECBE1

P1476

Q33587746-47B1CB80-6755-4EC8-ABC1-61311D6BA4C8

P2093

Q33587746-0B0AE200-6D3E-40FC-9AE5-AC70DF0F9C9B

Q33587746-18D9C7EF-8C22-41F4-AFE8-9F7DF03E0364

Q33587746-32FEA4C8-02C5-40C2-9360-486585FC5CF4

Q33587746-3AB05DDE-042F-43A7-AF26-16CF439A2662

Q33587746-466EE950-842E-4FE1-9E2D-8132863176D8

Q33587746-6039332D-EB66-4225-90F4-8C26C016A712

Q33587746-6C53541A-9A34-4CA9-84E6-410E1DAC536F

Q33587746-97B0BCC2-04F5-4AE7-81EC-BEF6EFA6D248

Q33587746-A80482D2-8CDE-457D-B714-4D17506F793D

Q33587746-B108E500-BBA1-402B-BB09-41FC5D63B7B8

P2860

Q33587746-076E5A96-CB9F-49E9-85DC-8596E8E72632

Q33587746-1C99DE68-9857-4533-9479-C600AD267418

Q33587746-204E10EA-379C-4FC0-B667-FAFA0A058E7A

Q33587746-305121B0-F941-4136-8A2B-94C1FB3B75C4

Q33587746-4D721AE3-758D-46F7-B1F9-FD0A08186A3E

Q33587746-5069589C-9C16-4A53-B39D-FD3720C3B9DC

Q33587746-58BB5ED0-C4D1-4F02-8A21-99ECD889763A

Q33587746-68D08262-DA91-4C25-A787-746C2AE6F027

Q33587746-8E007476-A6BE-4CC6-B863-9FD0842BB579

Q33587746-90A65419-9669-4BF4-8F96-2E189C729C15

P2888

Q33587746-7224C80B-233A-433B-BDAF-27134FCFF79C

P304

Q33587746-EDAE3B46-6C1A-4D6E-9381-50FF733E10AC

P31

Q33587746-4EA65311-BE56-4E59-BBAE-50E7C563DD6B

P356

Q33587746-D7E6A609-60E9-4947-86BD-07594EFB78BA

P433

Q33587746-79CA45A3-C6CD-4BE1-B0BF-1626843F8385

P478

Q33587746-5DA43D26-8200-4845-9237-BCF438D0F295

P577

Q33587746-9B0155A4-A15C-4231-9A10-0C3C9C0A209E

P6179

Q33587746-E05ABC6C-30DC-4968-A959-113A96B3F3EA

P698

Q33587746-A78D65B4-9273-427A-873D-9F61EF155A26

P356

S12032-010-9574-4

P1433

Medical Oncology

P1476

VARS2 V552V variant as prognostic marker in patients with early breast cancer.

@en

P2093

Byung Woog Kang

http://www.w3.org/2001/XMLSchema#string

Ho Yong Park

http://www.w3.org/2001/XMLSchema#string

Hye Jung Kim

http://www.w3.org/2001/XMLSchema#string

Ji Young Park

http://www.w3.org/2001/XMLSchema#string

Jin Hyang Jung

http://www.w3.org/2001/XMLSchema#string

Jong Gwang Kim

http://www.w3.org/2001/XMLSchema#string

Joon Ho Moon

http://www.w3.org/2001/XMLSchema#string

Sang Kyun Sohn

http://www.w3.org/2001/XMLSchema#string

Sang-Woo Lee

http://www.w3.org/2001/XMLSchema#string

Soo Jung Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration

Genotype versus phenotype: conflicting results in mapping a lung tumor susceptibility locus to the G7c recombination interval in the mouse MHC class III region.

First-line Herceptin monotherapy in metastatic breast cancer.

FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization.

Two common forms of the human MLH1 gene may be associated with functional differences

An editing-defective aminoacyl-tRNA synthetase is mutagenic in aging bacteria via the SOS response

Overexpression of human mitochondrial valyl tRNA synthetase can partially restore levels of cognate mt-tRNAVal carrying the pathogenic C25U mutation

Genetic polymorphisms in the DNA repair enzyme ERCC2 and breast tumour risk in a Chinese population.

Global effects of mistranslation from an editing defect in mammalian cells.

Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system.

P2888

s12032-010-9574-4

P304

1273-1280

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-010-9574-4

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1039925598

http://www.w3.org/2001/XMLSchema#string

P698

20503108

http://www.w3.org/2001/XMLSchema#string